Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-07 Purchase | 2024-02-08 4:30 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 21,000 | $2.4536 | $51,526 | 139,702 (Indirect Direct) | View |
| 2024-02-06 Purchase | 2024-02-07 4:22 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 20,000 | $2.5252 | $50,504 | 118,702 (Indirect Direct) | View |
| 2023-06-12 Purchase | 2023-06-12 4:31 pm | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 40,000 | $0.8 | $32,000 | 1,676,691 (Indirect Direct) | View |
| 2023-04-14 Purchase | 2023-04-14 6:16 pm | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 20,000 | $0.5499 | $10,998 | 1,636,691 (Indirect Direct) | View |
| 2023-04-11 Purchase | 2023-04-13 4:51 pm | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 60,000 | $0.48333 | $29,000 | 1,616,691 (Indirect Direct) | View |
| 2021-06-23 Purchase | 2021-06-23 5:12 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 10,000 | $7.6716 | $76,716 | 1,638,235 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Tax Withholding | 2024-04-12 5:01 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 518 | $2.79 | 160,192 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 5:01 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 1,675 | $0 | 160,192 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 5:54 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner | 155,277 | $0.29 | 1,973,968 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 5:03 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner | 142,000 | $0.24 | 1,818,691 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 5:04 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 18,750 | $0.8 | 1,556,691 (Direct) | View |
| 2022-12-31 Option Award | 2023-01-04 5:39 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 49,380 | $0 | 824,716 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-03 4:48 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 25,350 | $0 | 374,993 (Direct) | View |
| 2022-08-16 Gift | 2022-08-23 4:30 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 9,250 | $0 | 1,683,447 (Direct) | View |
| 2022-08-05 Tax Withholding | 2022-08-09 4:26 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 2,531 | $3.17 | 1,692,697 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-09 4:26 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 7,601 | $0 | 1,692,697 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:33 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 46,877 | $0 | 349,643 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-11 6:00 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 247,841 | $0 | 302,766 (Direct) | View |
| 2021-11-01 Option Award | 2022-04-04 5:45 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 15,001 | $0 | 64,847 (Direct) | View |
| 2021-12-31 Option Award(A) | 2022-01-06 5:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 6,722 | $0 | 22,780 (Direct) | View |
| 2021-09-30 Option Award(A) | 2022-01-06 3:57 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 6,024 | $0 | 16,058 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 5:34 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 6,722 | $0 | 6,722 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 4:36 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 6,024 | $0 | 6,024 (Direct) | View |
| 2021-08-05 Option Award | 2021-08-09 4:33 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 7,601 | $0 | 1,687,627 (Direct) | View |
| 2021-07-08 Option Award | 2021-07-09 4:33 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 23,337 | $0 | 31,464 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:04 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner | 8,127 | $0 | 8,127 (Direct) | View |
Ownership(A) | 2020-10-05 09:15 am | 2018-06-29 2021-06-29 | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer | 0 | $0 | 53,921 (Direct) | View |
Ownership | 2020-10-02 4:52 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer | 0 | $0 | 1,698,679 (Direct) | View |